Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
17-20 March, 2025
Pharmagora Plus 2025Pharmagora Plus 2025
Not Confirmed
Not Confirmed
08-09 March, 2025
Organic Process R&DOrganic Process R&D
Not Confirmed
Not Confirmed
10-12 March, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
17-20 March, 2025
Pharmagora Plus 2025Pharmagora Plus 2025
Industry Trade Show
Not Confirmed
08-09 March, 2025
Organic Process R&DOrganic Process R&D
Industry Trade Show
Not Confirmed
10-12 March, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/translational-pharmaceutics-our-flagship-platform-for-drug-development-empowers-our-clients-with-unparalleled-flexibility
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/top-first-in-class-drug-candidates-of-2025-ionis-donidalorsen-sanofi-s-fitusiran-cytokinetics-aficamten-await-fda-approval
05 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/05/3021635/0/en/Viracta-Therapeutics-Announces-Wind-Down-of-Operations.html
26 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/12/26/3002051/0/en/Viracta-Therapeutics-Announces-Closure-of-NAVAL-1-Clinical-Trial-and-Exploration-of-Strategic-Alternatives.html
13 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/13/2980086/0/en/Viracta-Therapeutics-Reports-Third-Quarter-2024-Financial-Results-and-Provides-Business-Update.html
07 Nov 2024
// BIOSPACE
https://www.biospace.com/job-trends/viracta-therapeutics-cuts-42-of-staff-as-part-of-resource-reprioritization
06 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/06/2976142/0/en/Viracta-Therapeutics-Announces-Reprioritization-of-Resources-to-Enhance-Focus-on-Nana-val-Development-Program-in-Patients-with-Relapsed-or-Refractory-EBV-Positive-Peripheral-T-Cell.html
03 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/03/2939516/0/en/Viracta-Therapeutics-to-Present-at-the-H-C-Wainwright-26th-Annual-Global-Investment-Conference.html
ABOUT THIS PAGE